- Details
- Description
-
Packaging Size56t/bottle
-
Strength200mg
-
CompositonElagolix
-
TreatmentEndometriosis
-
FormTablet
-
BrandLuciElag
-
Quantity Unit200mg*56t/Box
-
ManufacturerLucius Pharmaceuticals (Lao) Co.,Ltd
About Elagolix
Elagolix is a gonadotropin-releasing hormone antagonist (GnRH antagonist) medication which is used in the treatment of pain associated with endometriosis in women.
Endometriosis
Indicated for management of moderate-to-severe pain
Initiate with 150 mg PO qDay for up to 24 months
Coexisting conditions
- Dyspareunia: Consider initiating with 200 mg BID for up to 6 months
- Moderate hepatic impairment (Child-Pugh B): Initiate with 150 mg qDay for up to 6 months; 200 mg BID is not recommended
Dosage Modifications
Renal impairment
- No dosage adjustment required with any degree of renal impairment or end-stage renal disease (including dialysis)
Hepatic impairment
- Mild (Child-Pugh A): No dosage adjustment required
- Moderate (Child-Pugh B): Only the 150-mg qDay regimen is recommended for women with moderate hepatic impairment, and the duration of treatment should be limited to 6 months
- Severe (Child-Pugh C): Contraindicated
